Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Aligos Therapeutics (ALGS) Return on Assets (2021 - 2025)

Aligos Therapeutics filings provide 5 years of Return on Assets readings, the most recent being 0.0% for Q4 2025.

  • On a quarterly basis, Return on Assets rose 1.0% to 0.0% in Q4 2025 year-over-year; TTM through Dec 2025 was 0.0%, a 1.0% increase, with the full-year FY2025 number at 0.0%, up 1.0% from a year prior.
  • Return on Assets hit 0.0% in Q4 2025 for Aligos Therapeutics, up from 0.01% in the prior quarter.
  • In the past five years, Return on Assets ranged from a high of 0.0% in Q4 2025 to a low of 0.02% in Q4 2024.
  • Median Return on Assets over the past 5 years was 0.01% (2022), compared with a mean of 0.01%.
  • Biggest five-year swings in Return on Assets: decreased -1bps in 2024 and later rose 1bps in 2025.
  • Aligos Therapeutics' Return on Assets stood at 0.01% in 2021, then decreased by -20bps to 0.01% in 2022, then dropped by -20bps to 0.01% in 2023, then tumbled by -124bps to 0.02% in 2024, then surged by 85bps to 0.0% in 2025.
  • The last three reported values for Return on Assets were 0.0% (Q4 2025), 0.01% (Q3 2025), and 0.01% (Q2 2025) per Business Quant data.